Cartica Acquisition Corp Class A Ordinary Shares
CITE
CITE was delisted on the 10th of January, 2025.
43 hedge funds and large institutions have $129M invested in Cartica Acquisition Corp Class A Ordinary Shares in 2022 Q1 according to their latest regulatory filings, with 43 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$18.4M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$17.9M |
| 3 |
LA
Linden Advisors
New York
|
+$5.97M |
| 4 |
Millennium Management
New York
|
+$5.38M |
| 5 |
SV
Starboard Value
New York
|
+$5.37M |
Top Sellers
CITE Hedge Fund Activity: Q1 2022 in Review
43 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Cartica Acquisition Corp Class A Ordinary Shares (CITE) for Q1 2022, worth a combined $129M.
Buyers outnumbered sellers: 43 funds opened new CITE positions and 0 closed out — a net gain of 43 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $18.4M.
- 43 institutional investors held Cartica Acquisition Corp Class A Ordinary Shares (CITE) as of Q1 2022, up from 0 in Q4 2021.
- Funds reported $129M of Cartica Acquisition Corp Class A Ordinary Shares stock for Q1 2022.
- 43 funds opened new Cartica Acquisition Corp Class A Ordinary Shares positions in Q1 2022 and 0 closed out, a net change of +43 holders.
- The largest Cartica Acquisition Corp Class A Ordinary Shares buyer in Q1 2022 was Saba Capital Management, an estimated $18.4M added.
Based on aggregated 13F filings for Q1 2022.